Abstract: This paper studies the control-oriented recursive identification of finite impulse response systems with binary-valued observations. Inspired by the Maximum Likelihood method, a novel ...

BINARY ALGORITHM RESEARCH AND DEVELOPMENT PRIVATE LIMITED is a Private Limited Company, governed by the Companies Act as a company limited by shares. Classified as a Non-government company, it is ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

Meta announced on Tuesday a new Facebook algorithm update that will showcase more Reels videos tailored to users’ preferences. The update includes features that offer users greater control over the ...

Company shares partnership and clinical updates including $7 million Sanofi milestone and more information on patient populations for REC-1245 (RBM39) and REC-617 (CDK7) SALT LAKE CITY, Aug. 05, 2025 ...

SAN FRANCISCO--(BUSINESS WIRE)--Elastic (NYSE: ESTC), the Search AI Company, announced new performance and cost-efficiency breakthroughs with two significant enhancements to its vector search. Users ...

I am seeing numerous tests now that seem to prove that OpenAI's ChatGPT search feature is using Google Search's index or search results page to serve its own search results. First, Abhishek Iyer ...

This repository includes code implementations of various data structures in C, created while practicing and learning core data structure concepts. It covers structures and algorithms such as Arrays, ...

Google announced a new multi-vector retrieval algorithm called MUVERA that speeds up retrieval and ranking, and improves accuracy. The algorithm can be used for search, recommender systems (like ...

So, you want to get good at LeetCode, especially using Java? It’s a common goal for a lot of us trying to land those tech jobs. This guide is all about helping you get there. We’ll go over how to ...

Recursion's AI-enabled drug discovery platform continues to evolve, but this is yet to translate into meaningful clinical success. The recent cull of programs has further undermined investor ...